The presence of tumor-associated macrophages 2 (TAM2) with CD4+ T lymphocytes releasing IL4 [55] and myeloid-derived suppressor cells (MDSCs) [56,57] moves the TME in favor of tumor immune scape. This evidence concerns the gene CD4 and neoplasm.